Pharmacogenomic samples, testing and data handling - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document highlights some key principles to be considered by both the pharmaceutical industry and the assessors for pharmacogenomics sampling in clinical trials intended for regulatory submission.
Keywords: Pharmacogenomics (PG), pharmacogenomic evaluation